Ready Or Not, Dr Reddy’s Yields 1189% Returns

An investment of ₹1 lakh in Dr Reddy’s in November 2002, in 20 years your capital would have grown to ₹14.47 lakhs today. Here’s the multibagger that gave its investors returns of ₹11,89,240 and dividends of ₹1,58,340. Let’s take a sneak-peek at the company.

1189% Returns In 20 Years 🚀
₹1 Lakh Invested In November 2002, ₹14.47 Lakhs Today 💵
Returns of ₹11,89,240 + Dividends of ₹1,58,340 💰

💊 Stock Name: Dr Reddy’s Laboratories Ltd.
💊 NSE: $DRREDDY

⭐ About The Company
Incorporated in 1984 and headquartered in Hyderabad, Dr Reddy’s Laboratories is a pharmaceutical company founded by Kallam Anji Reddy. The company saw its start as a pharmaceutical ingredient producer, supplying necessary materials to Indian drug manufacturers from a 60-tonne manufacturing facility near Hyderabad.

🌎 Global Reach
At present, Dr Reddy’s is established in over 100 countries including the USA, Russia and other major countries in Europe. The company has 52 subsidiaries, facilitating over 1200 reactors, many of them approved by the US Food and Drug Administration (USFDA). In 2001, the company launched its US IPO for $132.8 million. It entered the UK market by acquiring two UK pharmaceutical firms in 2002.

💊 API Giant
Employing more than 21,000 individuals from 40 different nationalities, the company has about 60 active pharmaceutical ingredients and over 900 prescription and over-the-counter drugs. Primary customers of the organisation include doctors, nurses, pharmacists, chemists and patients.

Dr Reddy’s gained popularity internationally in the early 1990s, thanks to irregularities in the pharmaceutical markets. Once the company was established in these unregulated markets, getting approval from drug regulators in developed countries became easier.

🔮 Future Plans
With sustainability as the driver of its future expansion, the company aims to triple its patient count to 1.5 billion by 2030. The company also plans to increase the accessibility and affordability of its products for patients. According to the plan, Dr Reddy’s should be a water-positive corporation by 2025. Gender equality is underway in senior leadership, with the objective of having at least 35% women at that level.

💰 Stock Value
On November 1, 2002, the shares of the company were trading at ₹343.90, while they were priced at ₹4433.70 as of October 31, 2022.